China Research and Intelligence (CRI) has emerged to provide high-level research and advisory services to all those with keen interest in different Chinese markets and industries. The firm, founded in 2007, is headquartered in Shanghai, China. Their team’s principle goal is to present the most helpful and reliable insights and information, sincerely serving a broad choice of multinational and local customers with their business practice and ethics.
CRI’s reports are packed with precise analysis of key market indicators, strategic recommendations from industry experts, market estimated figures, projections, reviews of competitive strategies, consumers investigation, reviews of business models, market share analyses, key forces driving of restraining market growth.
CRI’s scope of offerings encircles numerous market research reports, industry analytical reviews, company business reports, industry-specific research databases. Further, the company also offers outsource and custom-tailored services for research organisations, and multiple report readers.
Publications found:
1,365
Sort by:
Investigation Report on China Letrozole Market, 2010-2019
US$ 2,000.00
... breast cancer and as the second-line drug for breast cancer. At home, Jiangsu Hengrui Medicine Co., Ltd was approved to market letrozole under the trade name of Furui in 1999, followed by Femara ...
August 2015
20 pages
Investigation Report on China Leuprorelin Market, 2010-2019
US$ 2,000.00
... Leuprorelin enjoys a vast demand in China. And Livzon, Beijing Biote Pharmaceutical Co., Ltd and Takeda Pharmaceutical Co., Ltd (Japan) occupy the market, among which Takeda Pharmaceutical Co., Ltd ...
August 2015
30 pages
Investigation Report on China Lumbrokinase Market, 2010-2019
US$ 2,000.00
... Lumbrokinase is a fibrinolytic enzyme present in the earthworm Lumbricus bimastus ... lumbrokinase sales in Chinese sample hospitals has dropped from CNY 54 million in 2010 to CNY 43.39 million in 2014. And in 2014, Beijing Baiao Pharmaceuticals Co., Ltd ...
August 2015
30 pages
Investigation Report on China Nifedipine Market, 2010-2019
US$ 2,000.00
... nifedipin by Bayer researchers in 1966 opened a new chapter in the treatment of cardiovascular diseases. Developed by Bayer in 1992, nifedipin controlled release tablet (Adalat) has given a new life to nifedipin ...
August 2015
30 pages
Investigation Report on China Sevoflurane Market, 2010-2019
US$ 2,000.00
... MARUISHI PHARMACEUTICAL CO.,LTD.(JA), Shanghai Hengrui Pharmaceutical Co., Ltd, BAXTER HEALTHCARE CORPORATION(US), Jiangsu Hengrui Medicine Co., Ltd and MARUKO(JA) occupy the market, among which MARUISHI PHARMACEUTICAL CO.,LTD ...
August 2015
30 pages
Investigation Report on China Temozolomide Market, 2010-2019
US$ 2,000.00
... temozolomide products available in the Chinese market come from the following four companies: Jiangsu Tasly Diyi Pharmaceutical Co., Ltd, Orion (Finland), Schering-Plough and Beijing SL Pharmaceutical Co., Ltd ...
August 2015
30 pages
Investigation Report on China Urokinase Market 2010-2019
US$ 2,000.00
... urokinase is widely used in treating such thrombotic diseases as acute myocardial infarction, cerebral thrombosis, pulmonary vein thrombus and deep vein thrombosis. With aging population and unreasonable eating habit, the incidence of thrombotic disease ...
August 2015
30 pages
Research Report on China Auto Parts Industry, 2010-2019
US$ 2,400.00
... auto parts competition in auto parts market in China import and export of auto parts in China major auto parts manufacturers in China expectation to auto parts industry in China The author suggests the following groups of people purchase this report: auto makers auto parts manufacturers ...
August 2015
60 pages
Research Report on China Wheat Industry, 2015-2019
US$ 2,200.00
... grain varieties in the world, wheat reported a yield of 126.21 million tons in 2014 in China, increasing 3.5% year on year. Wheat can not only make flour or fodder ... average consumption of flour as ration. Therefore, industrial use has become the major booster of wheat consumption. As wheat can also be used in ...
July 2015
50 pages
Investigation Report on China Quetiapine Market, 2010-2019
US$ 2,000.00
... disorder keeps going up, which fosters the vast demand for quetiapine in China. Currenly, Hunan Dongting Pharmaceutical Co., Ltd, Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory and AstraZeneca plc. occupy the majority of market share, among which AstraZeneca plc ...
July 2015
30 pages
Investigation Report on China Bevacizumab Market ,2010-2019
US$ 2,000.00
... China is higher than that in developed countries, it has decreased slightly in recent years. Developed by Roche under the trade name of Avastin, bevacizumab injection is the first angiogenesis inhibitor ...
July 2015
20 pages
Investigation Report on China Latanoprost Market, 2010-2019
US$ 2,000.00
... glaucoma provides a large market for conservative and postoperative medication. Therefore, latanoprost enjoys a vast demand in China. Pfizer Manufacturing Belgium NV, Pharmacia & Upjohn (Belgium), Lunan Better Pharmaceutical Co., Ltd, China Resources Zizhu Pharmaceutical Co., Ltd and Pharmacia & Upjohn ...
July 2015
30 pages
Investigation Report on China Pranoprofen Market, 2010-2019
US$ 2,000.00
... pranoprofen in China. Currently, pranoprofen in the Chinese market mainly come from the following three enterprises: Senju Pharmaceutical Co., Ltd, Shandong Haishan Pharmaceutical Co., Ltd and Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltd, among which Senju Pharmaceutical Co.,Ltd ...
July 2015
20 pages
Investigation Report on China Ranibizumab Market, 2012-2019
US$ 2,000.00
... ranibizumab made by different enterprises in China market outlook of ranibizumab in China The author suggests the following groups of people purchase this report: manufacturers of monoclonal antibody ...
July 2015
20 pages
Investigation Report on China Tobramycin Market, 2010-2019
US$ 2,000.00
... infection. Currently, dozens of enterprises in China are able to produce tobramycin, among which the TOP5 are s.a. Alcon-Couvreur n.v., Sine Pharma, Kangya of Ningxia Pharmaceuticals Co., Ltd, Guangzhou Baiyunshan Tianxin Pharmaceutical Co., Ltd and Shanghai Harvest Pharmaceutical Co., Ltd ...
July 2015
30 pages
Research Report on China Automobile Distribution Industry, 2010-2019
US$ 2,600.00
... automobile distribution industry in China key car dealers in China development trend of automobile distribution industry in China The author suggests the following groups of people purchase this report: car makers enterprises engaged in auto trade ...
July 2015
50 pages
Research Report on China Boiler Industry, 2010-2019
US$ 2,200.00
... boiler industry reason why gas-fired boiler replaced coal-burning boiler competition in boiler industry in China major boiler manufacturers in China expectation to boiler industry in China The author suggests the following groups ...
July 2015
50 pages
Research Report on China Machine Tool Industry, 2010-2019
US$ 2,400.00
... investment. For instance, the consumption of metal-cutting machine tool has decreased while that of metal-forming machine tool keeps growing. Besides, the import and domestic output of vertical machining center ...
July 2015
60 pages
Investigation Report on China Glipizide Market, 2010-2019
US$ 2,000.00
... China while other companies like Shandong Wanjie High-tech Co., Ltd, Yangtze River Pharmaceutical Group and Disha Pharmaceutical Group shared the rest market share. The annual sales value of glipizide ...
July 2015
30 pages
Investigation Report on China Gliquidone Market, 2010-2019
US$ 2,000.00
... Beijing Wanhui Double-Crane Pharmaceutical Co., Ltd took up a market share of about 97% for sales value in China while other companies like TIPR Pharmaceutical Responsible Co., Ltd, Jiangsu Vanguard Pharmaceutical Co., Ltd and Jilin Jinheng Pharmaceutical Co., Ltd and Shijiazhuang Yiling Pharmaceutical ...
July 2015
30 pages
Investigation Report on China Sorafenib Market, 2010-2019
US$ 2,000.00
... cancer and kidney cancer in China grows gradually. According to the Guidelines for Kidney Cancer Diagnosis and Treatment in China (the 2013 version), kidney cancer accounts for 2%-3% of adult malignant tumors in China ...
July 2015
20 pages
Research Report on China Photovoltaic (PV) Industry, 2015-2019
US$ 2,800.00
... China became the largest photovoltaic producer with export reaching USD 2.838 billion. In 2014, China’s total imports and exports of solar photovoltaic cell ... photovoltaic generation has developed fast in China. In 2014, the installed capacity of photovoltaic grid-connected generation in China ...
July 2015
60 pages
Investigation Report on China Parecoxib Market, 2010-2019
US$ 2,000.00
... analgesia. Parecoxib, the first COX-2 inhibitor which can be injected through vein and muscle, was developed by Pharmacia & Upjohn and approved to ... trade name of Dynastat in early 2002. Currently, it has been marketed in over 10 countries in the world. Parecoxib develops fast after entering China in 2008. ...
July 2015
25 pages
Investigation Report on China Ambroxol Market, 2010-2019
US$ 2,000.00
... Boehringer Ingelheim (Spain), Shenya Xin Ma Pharmaceutical Co., Ltd, Changzhou Siyao Pharmaceuticals Co., Ltd and Boehringer Ingelheim (Shanghai) occupy the majority of the Chinese market, among which Boehringer Ingelheim ...
July 2015
40 pages
Investigation Report on China Sertraline Market, 2010-2019
US$ 2,000.00
... China in 1996. Pfizer, Inc., Zhejiang Jingxin Pharmaceutical Co., Ltd, Tianjin Huajin Pharmaceutical Factory, Guangdong P.D. Pharmaceutical Co., Ltd and Chengdu Leer Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which Pfizer ...
July 2015
35 pages
Investigation Report on China Paroxetine Market, 2010-2019
US$ 2,000.00
... Ltd, GlaxoSmithKline plc (CA), Beijing Wansheng Pharmaceutical Co., Ltd, Zhejiang Huahai Pharmaceutical Co., Ltd and Zhejiang Jianfeng Pharmaceutical Holdings occupy the majority of the Chinese market, among which Sino-American Tianjin Smith Kline & French Laboratories Ltd ...
July 2015
35 pages
Investigation Report on China Lentinan Market, 2010-2019
US$ 2,000.00
... JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory, Chuang Li Yao Ye, Kanion Pharmaceutical, Nanjing Luye Sike Pharma Co., Ltd and Shanxi Zhendong Taisheng Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which JinLing Pharmaceutical Co., Ltd FuZhou MeiFeng Factory ...
July 2015
40 pages
Investigation Report on China Adefovir Market, 2010-2019
US$ 2,000.00
... GlaxoSmithKline (Tianjin) Co., Ltd, United Laboratories, Fujian Cosunter Pharmaceutical Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline (Tianjin) Co., Ltd ...
July 2015
35 pages
Investigation Report on China Lamivudine Market, 2010-2019
US$ 2,000.00
... GlaxoSmithKline Pharmaceuticals (Suzhou) Limited, Beijing Wansheng Pharmaceutical Co., Ltd, Burroughs Wellcome & Company (UK) and Fujian Cosunter Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline Pharmaceuticals (Suzhou) Limited ...
July 2015
35 pages
Investigation Report on China Polyene Phosphatidyl Choline Market, 2010-2019
US$ 2,000.00
... Chengdu Tiantaishan Pharmaceutical Co., Ltd, Shenzhen Sanofi Pasteur Biological Products Co., Ltd, Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd and Aventis Pharma S.p.A.(SP) occupy the majority of market share, among which Chengdu Tiantaishan Pharmaceutical Co., Ltd ...
July 2015
30 pages
Investigation Report on China Metformin Market, 2010-2019
US$ 2,000.00
... Sino-American Shanghai Squibb occupy about 80% of the metformin market in China while the rest market share is taken up by such companies as Liling and Hebei Ideal & Hightech Pharmaceutical Co., Ltd. Apart from diabetes, metformin ...
July 2015
30 pages
Investigation Report on China Nateglinide Market, 2010-2019
US$ 2,000.00
... Beijing Novartis Pharma Ltd. took up a market share of about 95% for sales value in 2014 while other companies like Deyuan Pharm, Luoxin Pharmacy Group Co., Ltd and Chia Tai Tianqing Pharmaceutical Group Co., Ltd together occupied about 5% of the nateglinide market in China ...
July 2015
30 pages
Investigation Report on China Glimepiride Market, 2010-2019
US$ 2,000.00
... Hangzhou Sanofi-Synthelabo Minsheng Pharmaceutical Co., Ltd took up a market share of about 86% for sales value and Sanofi occupied nearly 90% of the glimepiride market in China if Aventis (Italy ...
July 2015
30 pages
Investigation Report on China Gliclazide Market, 2010-2019
US$ 2,000.00
... Servier (France) and its subsidiary Servier (Tianjin) Pharmaceutical Co., Ltd took up a market share of about 96% for sales value in China while other companies like Tianjin Huajin Pharmaceutical Co., Ltd, Helioeast and Beijing Wansheng Pharmaceutical Co., Ltd ...
July 2015
30 pages
Investigation Report on China Olanzapine Market, 2010-2019
US$ 2,000.00
... holergasia. Mental illness has surpassed cancer and become the biggest threat to human health, ranking first in the total burden of disease in China. As an atypical antipsychotic, olanzapine ... life brought about by China’s economic development, the incidence of mental illness and psychological problems is growing. Therefore, the market size of olanzapine in China is expected to keep expanding ...
June 2015
25 pages
Investigation Report on China Alendronate Sodium Market, 2010-2019
US$ 2,000.00
... Merck Sharp & Dohme (Italy), CSPC Ouyi Pharmaceutical Co., Ltd, Beijing Wansheng Pharmaceutical Co., Ltd, Haini Pharmaceutical Co., Ltd and Chengdu Tiantaishan Pharmaceutical Co., Ltd occupy the majority of market share, among which Merck Sharp & Dohme ...
June 2015
30 pages
Investigation Report on China Zoledronic Acid Market, 2010-2019
US$ 2,000.00
... Novartis (Switzerland), Chia Tai Tianqing Pharmaceutical Group Co., Ltd, Jiangsu Hengrui Medicine Co., Ltd, Sichuan Hairong Pharmaceutical Co., Ltd and Jilin Province Xidian Pharmaceutical Sci-Tech Development Co., Ltd occupy the majority of the market share, among which Novartis ...
June 2015
30 pages
